Sometimes a single inherited marker helps make sense of a puzzling set of symptoms, HLA-B27 is a well-known example.
What happened
In 1973, researchers reported that the tissue-type marker HLA-B27 is strongly associated with ankylosing spondylitis, an inflammatory arthritis that mainly affects the spine and pelvis. Most people with the condition carry HLA-B27. Importantly, many healthy people carry it too, so the test supports the overall picture rather than proving the diagnosis on its own.
Why it mattered
In someone with suggestive symptoms, long-standing inflammatory back pain starting in early adulthood, an HLA-B27 result adds useful weight to the assessment and helps direct further investigation. It is a good example of how a genetic marker is interpreted alongside the clinical picture and imaging, not in isolation: a positive result raises the likelihood, and a negative one does not rule the condition out.
Key points
- HLA-B27 is a tissue-type (HLA) marker carried by some people
- It is strongly associated with ankylosing spondylitis and related conditions
- Most affected people are HLA-B27 positive, but many unaffected people are too
- The result is interpreted together with symptoms and imaging, not on its own
How this connects to our testing
This lab offers HLA-B27 molecular testing. See the Test List, or contact the lab to discuss sample requirements. Pricing is shared on enquiry.
Sources
Brewerton DA et al. and Schlosstein L et al.: independent reports of the strong association between HLA-B27 and ankylosing spondylitis, 1973. · General rheumatology references on the interpretation of HLA-B27 within the clinical picture.